Global Dermatophytosis Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 90 pages | ID: G1BC5880FEF0EN
QYResearch

Abstracts

This report focuses on the global Dermatophytosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dermatophytosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Novartis
• Pfizer
• Sanofi-Aventis
• Merck
• Enzon Pharmaceuticals
• Bayer
• Astellas Pharma
• GSK
• Abbott

Market segment by Type, the product can be split into

• Rx
• OTC

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Dermatophytosis Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Dermatophytosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Dermatophytosis Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dermatophytosis Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Dermatophytosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Rx
  1.4.3 OTC
1.5 Market by Application
  1.5.1 Global Dermatophytosis Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Dermatophytosis Therapeutics Market Perspective (2015-2026)
2.2 Dermatophytosis Therapeutics Growth Trends by Regions
  2.2.1 Dermatophytosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Dermatophytosis Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Dermatophytosis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Dermatophytosis Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Dermatophytosis Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Dermatophytosis Therapeutics Players by Market Size
  3.1.1 Global Top Dermatophytosis Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Dermatophytosis Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Dermatophytosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dermatophytosis Therapeutics Market Concentration Ratio
  3.2.1 Global Dermatophytosis Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Dermatophytosis Therapeutics Revenue in 2019
3.3 Dermatophytosis Therapeutics Key Players Head office and Area Served
3.4 Key Players Dermatophytosis Therapeutics Product Solution and Service
3.5 Date of Enter into Dermatophytosis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Dermatophytosis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Dermatophytosis Therapeutics Forecasted Market Size by Type (2021-2026)

5 DERMATOPHYTOSIS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Dermatophytosis Therapeutics Market Size by Application (2015-2020)
5.2 Global Dermatophytosis Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Dermatophytosis Therapeutics Market Size (2015-2020)
6.2 Dermatophytosis Therapeutics Key Players in North America (2019-2020)
6.3 North America Dermatophytosis Therapeutics Market Size by Type (2015-2020)
6.4 North America Dermatophytosis Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Dermatophytosis Therapeutics Market Size (2015-2020)
7.2 Dermatophytosis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Dermatophytosis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Dermatophytosis Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Dermatophytosis Therapeutics Market Size (2015-2020)
8.2 Dermatophytosis Therapeutics Key Players in China (2019-2020)
8.3 China Dermatophytosis Therapeutics Market Size by Type (2015-2020)
8.4 China Dermatophytosis Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Dermatophytosis Therapeutics Market Size (2015-2020)
9.2 Dermatophytosis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Dermatophytosis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Dermatophytosis Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Dermatophytosis Therapeutics Market Size (2015-2020)
10.2 Dermatophytosis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dermatophytosis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Dermatophytosis Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Dermatophytosis Therapeutics Market Size (2015-2020)
11.2 Dermatophytosis Therapeutics Key Players in India (2019-2020)
11.3 India Dermatophytosis Therapeutics Market Size by Type (2015-2020)
11.4 India Dermatophytosis Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Dermatophytosis Therapeutics Market Size (2015-2020)
12.2 Dermatophytosis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Dermatophytosis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Dermatophytosis Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novartis
  13.1.1 Novartis Company Details
  13.1.2 Novartis Business Overview and Its Total Revenue
  13.1.3 Novartis Dermatophytosis Therapeutics Introduction
  13.1.4 Novartis Revenue in Dermatophytosis Therapeutics Business (2015-2020))
  13.1.5 Novartis Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Dermatophytosis Therapeutics Introduction
  13.2.4 Pfizer Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Sanofi-Aventis
  13.3.1 Sanofi-Aventis Company Details
  13.3.2 Sanofi-Aventis Business Overview and Its Total Revenue
  13.3.3 Sanofi-Aventis Dermatophytosis Therapeutics Introduction
  13.3.4 Sanofi-Aventis Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.3.5 Sanofi-Aventis Recent Development
13.4 Merck
  13.4.1 Merck Company Details
  13.4.2 Merck Business Overview and Its Total Revenue
  13.4.3 Merck Dermatophytosis Therapeutics Introduction
  13.4.4 Merck Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.4.5 Merck Recent Development
13.5 Enzon Pharmaceuticals
  13.5.1 Enzon Pharmaceuticals Company Details
  13.5.2 Enzon Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Enzon Pharmaceuticals Dermatophytosis Therapeutics Introduction
  13.5.4 Enzon Pharmaceuticals Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.5.5 Enzon Pharmaceuticals Recent Development
13.6 Bayer
  13.6.1 Bayer Company Details
  13.6.2 Bayer Business Overview and Its Total Revenue
  13.6.3 Bayer Dermatophytosis Therapeutics Introduction
  13.6.4 Bayer Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.6.5 Bayer Recent Development
13.7 Astellas Pharma
  13.7.1 Astellas Pharma Company Details
  13.7.2 Astellas Pharma Business Overview and Its Total Revenue
  13.7.3 Astellas Pharma Dermatophytosis Therapeutics Introduction
  13.7.4 Astellas Pharma Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.7.5 Astellas Pharma Recent Development
13.8 GSK
  13.8.1 GSK Company Details
  13.8.2 GSK Business Overview and Its Total Revenue
  13.8.3 GSK Dermatophytosis Therapeutics Introduction
  13.8.4 GSK Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.8.5 GSK Recent Development
13.9 Abbott
  13.9.1 Abbott Company Details
  13.9.2 Abbott Business Overview and Its Total Revenue
  13.9.3 Abbott Dermatophytosis Therapeutics Introduction
  13.9.4 Abbott Revenue in Dermatophytosis Therapeutics Business (2015-2020)
  13.9.5 Abbott Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Dermatophytosis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Dermatophytosis Therapeutics Revenue
Table 3. Ranking of Global Top Dermatophytosis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dermatophytosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rx
Table 6. Key Players of OTC
Table 7. Global Dermatophytosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Dermatophytosis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Dermatophytosis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Dermatophytosis Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Dermatophytosis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Dermatophytosis Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Dermatophytosis Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Dermatophytosis Therapeutics Players
Table 18. Global Dermatophytosis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Dermatophytosis Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Dermatophytosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytosis Therapeutics as of 2019)
Table 21. Global Dermatophytosis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Dermatophytosis Therapeutics Product Solution and Service
Table 24. Date of Enter into Dermatophytosis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Dermatophytosis Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Dermatophytosis Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Dermatophytosis Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Dermatophytosis Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Dermatophytosis Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Dermatophytosis Therapeutics Market Share (2019-2020)
Table 34. North America Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Dermatophytosis Therapeutics Market Share by Type (2015-2020)
Table 36. North America Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Dermatophytosis Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Dermatophytosis Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Dermatophytosis Therapeutics Market Share (2019-2020)
Table 40. Europe Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Dermatophytosis Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Dermatophytosis Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Dermatophytosis Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Dermatophytosis Therapeutics Market Share (2019-2020)
Table 46. China Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Dermatophytosis Therapeutics Market Share by Type (2015-2020)
Table 48. China Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Dermatophytosis Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Dermatophytosis Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Dermatophytosis Therapeutics Market Share (2019-2020)
Table 52. Japan Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Dermatophytosis Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Dermatophytosis Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Dermatophytosis Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Dermatophytosis Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Dermatophytosis Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Dermatophytosis Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Dermatophytosis Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Dermatophytosis Therapeutics Market Share (2019-2020)
Table 64. India Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Dermatophytosis Therapeutics Market Share by Type (2015-2020)
Table 66. India Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Dermatophytosis Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Dermatophytosis Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Dermatophytosis Therapeutics Market Share (2019-2020)
Table 70. Central & South America Dermatophytosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Dermatophytosis Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Dermatophytosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Dermatophytosis Therapeutics Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Sanofi-Aventis Company Details
Table 85. Sanofi-Aventis Business Overview
Table 86. Sanofi-Aventis Product
Table 87. Sanofi-Aventis Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 88. Sanofi-Aventis Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Enzon Pharmaceuticals Company Details
Table 95. Enzon Pharmaceuticals Business Overview
Table 96. Enzon Pharmaceuticals Product
Table 97. Enzon Pharmaceuticals Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 98. Enzon Pharmaceuticals Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. Astellas Pharma Company Details
Table 105. Astellas Pharma Business Overview
Table 106. Astellas Pharma Product
Table 107. Astellas Pharma Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 108. Astellas Pharma Recent Development
Table 109. GSK Business Overview
Table 110. GSK Product
Table 111. GSK Company Details
Table 112. GSK Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 113. GSK Recent Development
Table 114. Abbott Company Details
Table 115. Abbott Business Overview
Table 116. Abbott Product
Table 117. Abbott Revenue in Dermatophytosis Therapeutics Business (2015-2020) (Million US$)
Table 118. Abbott Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Dermatophytosis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Rx Features
Figure 3. OTC Features
Figure 4. Global Dermatophytosis Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Dermatophytosis Therapeutics Report Years Considered
Figure 9. Global Dermatophytosis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Dermatophytosis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Dermatophytosis Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Dermatophytosis Therapeutics Market Share by Players in 2019
Figure 14. Global Top Dermatophytosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytosis Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Dermatophytosis Therapeutics Revenue in 2019
Figure 16. North America Dermatophytosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Dermatophytosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Dermatophytosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Dermatophytosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Dermatophytosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Dermatophytosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Dermatophytosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Novartis Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 27. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi-Aventis Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 29. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 31. Enzon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Enzon Pharmaceuticals Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 33. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bayer Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 35. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Astellas Pharma Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 37. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. GSK Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 39. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Abbott Revenue Growth Rate in Dermatophytosis Therapeutics Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed